The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances (TCRPS) was created to foster education and research on the field of medical applications of psychedelics, and one of them is specifically studying if remembering the psychedelic-induced hallucinations is a fundamental part of these substances' therapeutic effects.

The center’s director and a researcher in cancer and palliative care at the university’s school of pharmacy Dr. Paul Hutson explained that the “psychoactive substances” category includes drugs both holding hallucinogenic and non-hallucinogenic effects, which may have a wide range of direct mental health treatment applications.

The TCRPS seeks to collaborate both on campus and at a local level, it is currently leading a total of five clinical trials and plans to begin another two.

The study is evaluating the need for patients to actively remember …

Full story available on